Therapeutic Evaluation of Habb-E-Suranjan In Hyperuricemia
Published in December 2016 Issue 6 (Vol. 6, Issue 6, 2016)

Abstract
Authors (3)
Ehsan Rauf
Research Associate (Unani), Ce...Research Associate (Unani), Central Research Insti...Research Associate (Unani), Central Research Institute of Unani Medici...Research Associate (Unani), Central Research Institute of Unani Medicine, Lucknow, UP, India.
View all publications →M.Mohsin
Research Associate (Unani), Ce...Research Associate (Unani), Central Research Insti...Research Associate (Unani), Central Research Institute of Unani Medici...Research Associate (Unani), Central Research Institute of Unani Medicine, Lucknow, UP, India.
View all publications →Tabassum Latafat
Research Associate (Unani), Ce...Research Associate (Unani), Central Research Insti...Research Associate (Unani), Central Research Institute of Unani Medici...Research Associate (Unani), Central Research Institute of Unani Medicine, Lucknow, UP, India.
View all publications →Download Article
Summarise this paper with AI:
Article Information
Published in:
December 2016 Issue 6 (Vol. 6, Issue 6, 2016)Article Impact
How to Cite
Rauf, E., M.Mohsin, & Latafat, T. (2016). Therapeutic Evaluation of Habb-E-Suranjan In Hyperuricemia. American Journal of PharmTech Research, 6(6), 1-13. https://ajptr.com/articles/AJPTR66043
Article Actions
More from this Issue
Pulsatile Drug Delivery System: A Review
Lichen Secondary Metabolites and Its Biological Activity
A Review on Time Dependent Pharmacokinetics
More by These Authors
Formulation and Evaluation of Floating Matrix Tablets of Dipyridamole
2015 • Vol. 5, Issue 4
Read more →Balancing Efficacy and Safety: An In-Depth Review of Diclofenac-Associated Adverse Effects
2025 • Vol. 15, Issue 6
Read more →Temperature and Frequency dependent dielectric properties of groundnut oil
2017 • Vol. 7, Issue 4
Read more →